Detalhe da pesquisa
1.
A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).
Circulation
; 139(2): 192-205, 2019 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586746
2.
Development of a flow cytometry-based pulse-width assay for detection of aggregates in cellular therapeutics to be infused by catheter.
Cytotherapy
; 16(11): 1545-1557, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24972743
3.
Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancers.
Lung Cancer
; 162: 23-28, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34655925
4.
Phase I dose-escalation studies of SNX-5422, an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumours.
Eur J Cancer
; 50(17): 2897-904, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25262379
5.
Phase I trial of the HSP90 inhibitor PF-04929113 (SNX5422) in adult patients with recurrent, refractory hematologic malignancies.
Clin Lymphoma Myeloma Leuk
; 13(4): 385-91, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23763921